Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Income from Non-Controlling Interests (2022 - 2025)

Historic Income from Non-Controlling Interests for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$628000.0.

  • PAVmed's Income from Non-Controlling Interests changed N/A to -$628000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year change of. This contributed to the annual value of -$11.4 million for FY2024, which is 2468.19% up from last year.
  • Latest data reveals that PAVmed reported Income from Non-Controlling Interests of -$628000.0 as of Q3 2025.
  • In the past 5 years, PAVmed's Income from Non-Controlling Interests registered a high of -$289000.0 during Q4 2024, and its lowest value of -$4.3 million during Q1 2023.
  • Its 4-year average for Income from Non-Controlling Interests is -$2.7 million, with a median of -$3.4 million in 2023.
  • Per our database at Business Quant, PAVmed's Income from Non-Controlling Interests crashed by 5512.5% in 2023 and then skyrocketed by 9142.94% in 2024.
  • Over the past 4 years, PAVmed's Income from Non-Controlling Interests (Quarter) stood at -$4.1 million in 2022, then grew by 18.0% to -$3.4 million in 2023, then soared by 91.43% to -$289000.0 in 2024, then crashed by 117.3% to -$628000.0 in 2025.
  • Its last three reported values are -$628000.0 in Q3 2025, -$403000.0 for Q2 2025, and -$345000.0 during Q1 2025.